Clinical Trial Update: Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial [Phase 2]

View source ↗

Summary

A completed Phase 2 multicenter trial evaluating the feasibility of risk-adapted therapy for young adults with acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED